Medical Condition

crohn s disease

Total Trials

19

Recruiting Now

19

Trial Phases

Phase 2, Phase 1, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for crohn s disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — crohn s disease Clinical Trials

How many clinical trials are currently recruiting for crohn s disease?

ClinicalMetric currently tracks 19 actively recruiting clinical trials for crohn s disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 19. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for crohn s disease?

crohn s disease research spans Phase 1 (1 trial), Phase 2 (3 trials), Phase 3 (5 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a crohn s disease clinical trial?

Eligibility criteria for crohn s disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Phase 4

Top Sponsors

Takeda 3 trials

Sixth Affiliated Hospital, Sun Yat-sen University 2 trials

Kazakhstan Scientific Society for Study of intestine diseases 1 trial

AbbVie 1 trial

Icahn School of Medicine at Mount Sinai 1 trial

crohn s disease

Frequently Asked Questions — crohn s disease Clinical Trials

Recruiting Clinical Trials

Clinical Efficacy of Ustekinumab in Crohn's Disease

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World Setting

Behavioral Therapy for Crohn's Disease

Pregnancy and Inflammatory Bowel Disease

An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

Helmsley 3.0: Abbreviated MRE

A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease

Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease

Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease

Real-World Study of IL-23 Inhibitors in Active Crohn's Disease

Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)